MK-4884 / Merck (MSD) - LARVOL DELTA

Clinical Study of MK-4884 in Participants With Advanced or Metastatic Solid Tumors (MK-4884-001) (clinicaltrials.gov) - P1 | N=120 | Recruiting | Sponsor: Merck Sharp & Dohme LLC | Not yet recruiting ➔ Recruiting

Enrollment open • Biliary Tract Cancer • Cholangiocarcinoma • Gallbladder Cancer • Lung Cancer • Lung Non-Squamous Non-Small Cell Cancer • Non Small Cell Lung Cancer • Oncology • Renal Cell Carcinoma • Solid Tumor